Clinical Trial Update: Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease

View source ↗

Summary

Post-marketing surveillance study of Bixalomer in pre-dialysis chronic kidney disease patients has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Bixalomer (bixalomer)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Chronic Kidney Disease | Status: COMPLETED